Tradestie Institutional Equity Comparison Engine

ESTA vs RBOT.WS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ESTA Overall Edge

ESTA Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Establishment Labs Holdings Inc. (ESTA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ESTA trades at N/M Forward P/E with -6.6% operating margin (+33.9% YoY revenue) versus RBOT.WS at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ESTA sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro) against RBOT.WS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ESTA N/M vs RBOT.WS N/M Fwd P/E
Growth & Margin Winner ESTA
Op Margin -6.6% vs N/A ยท YoY +33.9% vs N/A
Momentum & Technical Winner ESTA
1Y +3.4% vs -67.2% ยท 52W Pos 36% vs 0%
Options & Structure Winner ESTA
CONSOLIDATION (5th %ile IV) vs UNCLASSIFIED (N/A IV)
ESTA NASDAQ
Establishment Labs Holdings Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$69.14
-0.68% 1D
Market Cap $2.1B
1M Return +8.85%
1Y Return +3.44%
Forward P/E N/M
Unified AI Score
35.7 / 100 SELL
Tech 35.0 Fund 40.0 Flow 61.0 Mom 21.4
RBOT.WS NYSE
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.01
-24.77% 1D
Market Cap N/A
1M Return -67.2%
1Y Return -67.2%
Forward P/E N/M
Unified AI Score
50.1 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ESTA +3.44% RBOT.WS -67.2% Spread: +76.84 pp (ESTA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ESTA TTM Op. Margin: -6.6% RBOT.WS TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ESTA vs RBOT.WS. Trailing 12-month operating profitability (ESTA -6.6% vs RBOT.WS N/A) and valuation multiples (ESTA N/M vs RBOT.WS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ESTA (7) vs RBOT.WS (1)
Institutional Metric ESTA RBOT.WS Criterion Row Winner
Market Capitalization Scale $2.1B N/A Larger Scale ESTA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +33.9% N/A Higher Growth ESTA
Operating Margin (TTM) Profitability -6.6% N/A Higher Margin ESTA
Net Profit Margin Profitability -14.6% N/A Higher Margin ESTA
Return on Equity (ROE) Capital Efficiency -240.7% N/A Higher ROE ESTA
52-Week Range Position Momentum 36% ($53โ€“$98) 0% ($0โ€“$0) Stronger Trend ESTA
Beta / 30D Volatility Risk Regime 1.49ฮฒ ยท 57% Vol N/A Lower Realized Risk ESTA
Unified Institutional Score Composite Signal 35.7 / 100 (SELL) 50.1 / 100 (HOLD) Higher Composite RBOT.WS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ESTA vs RBOT.WS Buy Guide
ESTA CONSOLIDATION
105d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live ESTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RBOT.WS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RBOT.WS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ESTA nor RBOT.WS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.